Navigation Links
Subterfuge, counter-surveillance and assassination: The body's fight with cervical cancer
Date:3/20/2008

The virus responsible for most cases of cervical cancer has a serious weakness which may provide hope for new treatments for the disease.

Human Papillomavirus (HPV), a virus which causes several types of cancer but is particularly associated with cervical cancer, has developed clever ways of hiding in the body, but researchers at the University of Leeds have found that its ability to trick the bodys first line of defence leaves it vulnerable to attack from a second defence system.

When viruses enter cells, they produce proteins to assist their growth and replication, and the bodys immune system is programmed to recognise and attack these non-native proteins.

Professor Eric Blair of the Universitys Faculty of Biological Sciences and Dr Graham Cook from the Leeds Institute for Molecular Medicine have been specifically looking at one of the proteins produced by HPV, called E7, and have discovered that it suppresses markers on the cell surface, making infected cells much less visible to T cells, one of the bodys key defence systems.

T cells can normally tell when there are molecules in the body that shouldn't be there and activate an immune response, says Professor Blair. But HPV uses the E7 protein to hide from them. We've always known the virus has clever ways of defending itself, but we now know how one of its main defence mechanism works.

However, in a twist that offers hope for the development of potential new therapies for cervical cancer, Professor Blair and Dr Cook have also discovered that this subterfuge may be the viruss downfall.

Cells without surface protein markers are targeted by another of the bodys white blood cell armoury, Natural Killer cells - cellular assassins, which when activated, release specialised enzymes into target cells to kill them.

Despite the bodys valiant efforts to ward off the virus, women are still contracting this awful disease, so there are clearly other mechanisms at work. We need to look at the role of the other components of the virus, to see if they prevent the Natural Killer cells from attacking, says Professor Blair. For example, weve started examining the contribution of the virus protein E6, which we believe works in partnership with E7. The recent introduction of a vaccine against HPV is an important development in the fight against cervical cancer. However, it may take many years for the vaccine to reduce the number of cases of this cancer and other approaches to eliminating tumour cells need to be discovered.

This research was funded by Yorkshire Cancer Research, the charitys Chief Executive, Elaine King commented: Human Papillomavirus is extremely complex with many mechanisms affecting how it operates. However, through this research we have discovered how the E7 protein works, which is a huge step forward, and will hopefully help us to develop effective ways to combat Human Papillomavirus in the future.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert

Related biology news :

1. Fighting Aussie yabbies dont forget a face -- new research by the University of Melbourne
2. Taking the fight against cancer to heart
3. Marsupial lion tops African lion in fight to death
4. Fighting pollution the poplar way: Trees to clean up Indiana site
5. Researchers uncover key trigger for potent cancer-fighting marine product
6. New drug targets may fight tuberculosis and other bacterial infections in novel way
7. Tiny pest-eating insect fights fruit flies
8. Worlds most endangered gorilla fights back
9. New research to help fight widespread potato disease
10. Potential new therapeutic molecular target to fight cancer
11. Gamma interferon could aid fight against fungal infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
Breaking Biology Technology: